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Abstract 
The  aims  of  this  study  were  to  evaluate
through  Color  Doppler  Myocardial  Imaging
(CDMI) echocardiography if atrial or ventricu-
lar myocardial alterations could be detectable
in  patients  with  thalassemia  major  (THAL)
and if these alterations could be considered as
predictive  elements  for  supra-ventricular
arrhythmic events. Twenty-three patients with
THAL  underwent  clinical  and  electrocardio-
graphic evaluation; patients were grouped in
THAL1 (9 with supra-ventricular arrhythmias)
and  THAL2  (14  without  arrhythmias);  12
healthy  subjects  were  considered  as  control
group (C). We examined through convention-
al 2D Color Doppler echocardiography some
morphological  and  functional  parameters
regarding  left  ventricular  (LV)  systolic  and
diastolic  function,  and  through  CDMI  the
velocities at mitral annulus level, the regional
LV and left atrial (LA) strain and strain rate.
All THAL patients had LV dimension (p<0.05),
LA area (p<0.01) and E/Em ratio (p<0.001) to
be  significantly  higher  than  controls.  The
mitral  annulus  longitudinal  velocities  were
significantly lower in THAL1 than in THAL2
(p<0.001);  the  E/Em  ratio  was  higher  in
THAL1  than  THAL2  (p<0.001).  The  THAL1
showed a lower systolic strain rate of atrial
wall than THAL2 and C (p<0.05). The multiple
regression highlighted a significantly inverse
correlation  among  E/Em  and  atrial  strain
(p<0.02). CDMI showed both THAL subgroups
had subtle systolic and diastolic left ventricu-
lar myocardial alterations, which could repre-
sent the onset of developing “iron cardiomy-
opathy” and are related to supra-ventricular
arrhythmia. Monitoring these parameters in
the  THAL  patients  could  contribute  to  deci-
sions about follow-up and therapy. 
Introduction
Iron overload represents the most important
cause of mortality and morbility in patients
affected by thalassemia major (THAL).
1 A pre-
vious  Italian  case  study  recognized  in  the
“iron  overload  cardiomyopathy”  the  main
cause of mortality in THAL (63.3%), followed
by  infections  and  hepatic  diseases.
2 More
recent  studies  confirmed  these  results  and
discovered  a  higher  percentage  of  survival
among those patients born after the introduc-
tion of the chelation therapy with desferoxam-
ine.
3 However, even patients treated with peri-
odical  transfusions  and  intensive  chelation
suffer at a certain point from cardiomyopathy
4
and of arrhythmic symptoms, most frequently
ventricular, which still constitute a recurrent
complication  in  the  natural  development  of
the disease.
2,3
Traditional  morphological  and  functional
qualitative  analysis  of  the  heart  through  M-
mode, B-mode and color Doppler echocardiog-
raphy can now be greatly improved by a rela-
tively  new  ultrasonic  methodology,  the  Color
Doppler  Myocardial  Imaging  (CDMI)  that
allows  a  better  quantitative  description  of
myocardium  regional  longitudinal  function.
5,6
Furthermore, CDMI could be able to detect early
alterations of intramyocardial function, crucial
in  our  complex  physiopathological  model,  in
which iron intramyocardial deposit is consid-
ered the most responsible for cardiomyopathy
in these patients. CDMI allows the analysis of
myocardial strain and strain rate, which are not
affected by rotational movement of the heart, by
tethering effect, or by load conditions.
6 On the
other hand, the analysis of left atrial function
through CDMI is still to be fully explored.
7-10 In
our  study,  the  analysis  of  atrial  deformation
could have a significant incremental value both
integrating the diagnostic findings of myocar-
dial CMDI functional analysis and adding prog-
nostic  information  about  the  potentiality  of
generating atrial arrhythmias. 
The aims of the study were: a) to test, in
THAL patients, if CDMI is able to detect the
presence of even early, sub clinical structural
and  functional  alterations  of  the  atrial  and
ventricular  myocardium,  which  could  be
referred to as “iron overload cardiomyopathy”;
and b) to obtain predictive elements of supra-
ventricular arrhythmias. 
Materials and Methods 
Twenty-three  patients  (13  males  and  10
females) with THAL underwent a clinical eval-
uation, electrocardiography and transthoracic
conventional  echocardiography  and  CDMI.
These  patients  were  grouped  into  two  sub-
groups: THAL1, 9 pts (6 males and 3 females)
who had supra-ventricular arrhythmias (atrial
tachycardia, atrial flutter, atrial fibrillation) in
the last six months and THAL2, 14 pts (7 males
and  7  females)  without  arrhythmias.  All
patients in this study were both under regular
hematic  transfusions,  with  the  last  transfu-
sion  given  seven  days  before  the  test  and
under chelating therapy with desferoxamine
in individual doses and were part of 157 THAL
patients  periodically  evaluated  in  our  Echo-
Lab.  Serum  ferritine  concentrations  were
measured to assess the efficacy of iron chela-
tion therapy. Full blood count and liver and
renal  function  assessment  were  periodically
performed. Twelve healthy subjects (9 males
and  3  females)  were  considered  as  control
group(C).
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Conventional 2D-Doppler echocardiography
Studies were performed using a commercially
available  digital  echograph  GE  System  Five,
equipped with a broadband sector transducer, fol-
lowing the digital echocardiography Guidelines of
the American Society of Echocardiography.
11 Left
ventricular  mass  was  calculated  according  to
Devereux’s formula;
12stroke volume was calculat-
ed as the difference between end-diastolic vol-
ume and end-systolic volume, while the cardiac
output was calculated according to the formula:
stroke volume x heart rate. With this method we
analyzed the following main parameters:
- left  ventricle  internal  diastolic  and  systolic
dimensions, respectively LVIDd, LVIDs;
- septum and posterior wall thickness in diastole
and in systole, respectively IVSd, IVSs, PWd, PWs;
- left atrium systolic diameter (LAD) and area
(LAarea);
- left ventricular systolic (ESV) and diastolic vol-
umes  (EDV)  and  relative  ejection  fraction
(LVEF);
- left ventricular mass both in absolute (LVM)
and indexed value by BSA (LVM/BSA);
- early and late transmitral flow peak velocities
and their ratio (PeakE, PeakA, E/A ratio).
Pulsed wave tissue doppler imaging 
In the apical four chamber views, the PW
Doppler  sample  volume  was  subsequently
placed in 2 different sites of mitral annulus:
septal and lateral. The apical 4-chamber view
was  chosen  to  obtain  a  quantitative  assess-
ment of the global diastolic left ventricular lon-
gitudinal  function,  almost  simultaneously  to
the Doppler left ventricular inflow, and to min-
imize the incidence angle between the Doppler
beam  and  the  longitudinal  motion  of  mitral
annulus.
13,14 The pattern of PW shows a systolic
wave (Sm) and two diastolic waves that corre-
sponded to early (Em) and late (Am) diastole,
respectively. The following measurements were
determined  in  each  place  as  index  of  global
diastolic  function,  peak  velocities  of  the  Em
and Am waves (cm/sec) and their ratio. Peak
velocities of Sm (cm/sec) were calculated as
indices of global systolic function.
14 PW tissue
Doppler of Em was used for the measurement
of early peak diastolic mitral annulus velocity
and  left  ventricular  filling  pressures  were
approximated from the relationship of E/Em (E
being the early peak mitral flow velocity).
15 
CDMI derived-indices: strain rate and strain
CDMI  has  been  recently  introduced  as  a
method to evaluate regional myocardial func-
tion by providing a map of color-encoded tissue
velocities. This methodology enables us to cal-
culate, from regional mean velocities, strain
rate  (SR)  and  the  relative  strain  (ʵ).
5,6 The
concept  of  regional  myocardial  strain  was
defined  as  fractional  tissue  deformation  in
response to an applied force (stress) and by
definition  negative  strain  means  shortening
and positive strain elongation. Strain rate is
the speed at which deformation (i.e. strain)
occurs (expressed in s
–1). In echocardiography,
SR can be calculated by measuring the instan-
taneous velocity gradient across a deforming
piece of tissue:
16,17 strain (ʵ) and strain rate
(SR) both at basal segments of interventricu-
lar septum (IVS) and of lateral wall (LVW) and
at  distal  segments  of  the  interatrial  septum
(IAS) and of atrial lateral wall (LAW), consider-
ing the ʵ and SR systolic peak and the SRpeak
in early and late diastole (E and A) (Figure 1).
Statistical analysis
Continuous  variables  were  expressed  as
mean values±Standard Deviation. The statis-
tical comparison between groups was made
using  analysis  of  variance  and  unpaired
Student’s t-test was used for subgroup com-
parison. The statistical significance level was
placed at p<0.05. Variables with a p<0.10 at
univariate analysis were entered into multi-
variate multiple linear regression analysis to
identify independent predictors of E/Em ratio
regression.
Figure 1. Color doppler myocardial imaging: apical 4 chamber views of interested areas
at basal segments of interventricular septum and lateral wall, at distal segments of the
interatrial septum and atrial lateral wall. In graphics the traces of strain rate at selected
points.
Table 1. Demographic and conventional echo parameters.
THAL1 (9) THAL2 (14) C (12)
BSA (m
2) 1.55±0.1
ﾰ ﾰ ﾰ 1.54±0.2
ˈˈ 1.83±0.2
Age (yrs) 35.33±6.9
§§ ﾰ  26.29±5.6 27.33±9.0
Hb (g%) 11.2±1.4 10.8±1.3 -
Ferritin (mg/L) 2144±2132 2383±1859 -
LVIDd (cm) 5.54±0.6
§§ ﾰ  4.93±0.5 4.91±0.6
LVIDd/BSA 3.58±0.4
ﾰ ﾰ ﾰ 3.26±0.6
ˈˈ 2.68±0.3
LVIDs (cm) 3.66±0.7
ﾰ  3.17±0.5 3.09±0.5
LVEF (%) 68.89±11.0 73.21±6.9 74.67±5.5
LAD (cm) 4.08±0.7
§§ ﾰ  3.44±0.4 3.42±0.5
LAD/BSA 12.30±3.7
ﾰ ﾰ ﾰ 10.08±1.7
ˈˈˈ 7.51±0.7
LA area (cm
2) 18.97±5.5 
§ ﾰ ﾰ  15.27±1.8
ˈ 3.74±1.7
THAL1 vs THAL2: 
§p<0.05; 
§§p<0.01; 
§§§p<0.001; THAL1 v.s C: 
ﾰ p<0.05; 
ﾰ ﾰp<0.01; 
ﾰ ﾰ ﾰp<0.001; TAHL2 vs. C: 
ˈp<0.05; 
ˈˈp<0.01; 
ˈˈˈp<0.001.
BSA: Body surface area; Hb: Hemoglobin; LVIDd: Left ventricle internal diastolic dimensions; LVIDs: Left ventricle internal systolic dimen-
sions; LVEF: Left ventricular ejection fraction; LAD: Left atrium systolic diameter; LAarea: Left atrium area.Article
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Results
The THAL1 group consisted of 9 patients
with previous supra-ventricular arrhythmia:
3  patients  with  atrial  fibrillation  episodes,
one atrial tachycardia and 5 supra-ventricu-
lar parossistic tachycardia. Main demograph-
ic characteristics of the study population are
shown  in  Table  1.  Thalassemic  patients
showed a lower BSA compared to group 1 C.
THAL1 patients were significantly older com-
pared to group C and THAL2, whereas there
were  no  differences  between  THAL  patient
groups  in  hemoglobin  and  ferritin  values.
THAL1 patients showed a significantly higher
LVID (also indexed: LVIDd/BSA), LAD and LAarea
values if compared to THAL2 and C. No study
group showed significant differences in LVEF
values.  The  transmitral  flow  velocity  and
myocardial  velocity  at  mitral  annulus  are
shown in Table 2. No differences were found
in diastolic function if analyzed by transmi-
tral flow velocities, whereas the myocardial
velocities at mitral annulus level, both in sys-
tole and in diastole, were significantly lower
in THAL1 than those of THAL2 and C, and
E/Em ratio was higher in all THAL groups in
comparison with C, and significantly higher
in THAL1 compared with THAL2. In THAL1,
patients presented an E/Em ratio ≥8 and 2 of
them >10; no patients had E/Em ratio >15. In
THAL2, 6 patients presented an E/Em ratio ≥8
and none >10. The ventricular deformability,
expressed by strain and strain rate, is shown
in  Table  3.  THAL1  and  THAL2  had  a  lower
ventricular  longitudinal  deformability,  with
the lower level of systolic strain if compared
to C; early (E) and late (A) diastolic SR peak
at IVS and LVW level was significantly lower
on THAL1 compared to THAL2 and C. Atrial
deformation  analysis  is  shown  in  Table  4.
Strain and the SR peak values at atrial later-
al wall were significantly lower in THAL1 if
compared both with THAL2 and C, while at
interatrial  septum  only  SR  peak  A  values
were  significantly  lower  in  comparison  to
THAL2  and  C.  By  performing  univariate
analysis in the THAL1 population, the E/Em
ratio  at  lateral  mitral  annulus  was  signifi-
cantly  related  to  LAW  SR-Epeak (R=0.681,
p<0.044,  ʲ-coefficient  0.635).  While  the
E/Em ratio at septal mitral annulus was sig-
nificantly related to LVW SR-Epeak (R=0.785,
p<0.027,  ʲ-coefficient  -1.282).  In  THAL2
E/Em ratio at septal mitral annulus was sig-
nificantly related to IVS SR-Epeak (R=0.563,
p<0.036,  ʲ-coefficient  -0.734),  LVWʵ
(r=0.480, p<0.027, ʲ-coefficient -0.069).
By performing multiple linear regression
analysis in an overall thalassemic population
E/Em ratio at lateral mitral annulus showed
the  best  correlation  to  LAW  SR-Speak
(R=0.425 p<0.05, ʲ-coefficient -0.695). E/Em
ratio  at  septal  mitral  annulus  showed  the
best correlation to LVW SR-Epeak (R= 0.599
p<0.003, ʲ-coefficient -1.056) (Figures 2 and
3). No significant differences in hemoglobin
and  ferritin  were  found  among  any  tha-
lassemic  group  and  no  significant  correla-
tions  were  identified  in  comparison  with
echocardiographic parameters.
Discussion
The main findings of the present study are :
a)the early detection through CDMI of systolic
left  ventricular  dysfunction  (significantly
lower myocardial deformability, i.e. strain);
these alterations are more pronounced in
Table 2. Transmitral flow velocities and PW-TDI doppler at mitral annulus level.
THAL1 (9) THAL2 (14) C (12)
PeakE (m/s) 0.94±0.1 0.96±0.2 0.82±0.1
PeakA (m/s) 0.47±0.1 0.54±0.1 0.48±0.1
E/A 2.25±1.2 1.81±0.4 1.79±0.5
Annulus side Septal Lateral Septal Lateral Septal Lateral
Sm (cm/s) 6.3±1.3
§ ﾰ ﾰ  6.9±1.9
§ﾰ ﾰ  7.7±1.2
ˈ 8.6±2.4 9.2±2.2 9.6±2.1
Em (cm/s) 9.5±1.4
§§§ﾰ ﾰ  12.1±2.9
§§§ﾰ  12.8±2.1 16.9±3.1 13.8±4.2 17.1±5.0
Am (cm/s) 5.1±1.4
§§ﾰ ﾰ  4.9±1.8
§§§ﾰ  6.9±1.6 8.1± 2.2 7.6±1.6 7.5±3.0
E/Em 10.3±2.5
§§ﾰ ﾰ ﾰ  9.0±2.2
§§§ﾰ ﾰ ﾰ  7.6±1.3
ˈ 5.8±1.3
ˈ 5.9±3.4 4.8±2.8
THAL1 vs. THAL2: 
§p<0.05; 
§§p<0.01; 
§§§p<0.001; THAL1 vs. C: 
ﾰp<0.05; 
ﾰ ﾰp<0.01; 
ﾰﾰ ﾰ ﾰp<0.001; TAHL2 vs. C: 
ˈp<0.05; 
ˈˈp<0.01; 
ˈˈˈp<0.001.
Transmitral flow velocities: PeakE: early peak velocities; PeakA: late peak velocities; E/A: ratio between PeakE and PeakA Pulsed Wave
Tissue Doppler Imaging; Sm: systolic wave; Em: early diastolic wave; Am: late diastolic wave; E/Em ratio between PeakE and Em.
Table 4. Atrial deformation.
THAL1 (9) THAL2 (14) C (12)
IAS SRpeak S 2.94±1.7 2.66±1.7 2.97±1.7
E -4.00±2.6 -4.18±1.8 -3.15±2.5
A -1.38±1.9
§ -2.30±1.1 -2.10±0.9
IAS ʵ S 39.1±24.5 46.8±13.1 46.8±16.4
LAW SRpeak S 1.09±0.9
§§ ﾰ  2.71±1.5 2.56±1.
E -2.87±2.4 -4.12±1.7 -4.11±1.9
A -1.12±1.5
§ -2.58±1.4 -2.17±2.0
LAW ʵ S 21.3±13.2
§ 36.2±15.6 37.1±14.9
THAL1 vs. THAL2: 
§p<0.05; 
§§p<0.01; 
§§§p<0.001; THAL1 vs. C: 
ﾰp<0.05; 
ﾰ ﾰp<0.01; 
ﾰﾰ ﾰ ﾰp<0.001; TAHL2 vs. C: 
ˈp<0.05; 
ˈˈp<0.01; 
ˈˈˈp<0.001.
IAS SRpeak: strain rate systolic (S), early (E) and late (A) diastolic peak at distal segments of interatrial septum; IASε: strain systolic (S)
peak at distal segments of interatrial septum LAW SRpeak: strain rate systolic (S), early (E) and late (A) diastolic peak at distal segments
of left atrial lateral wall; LAWÂ: strain systolic (S) peak at distal segments of left atrial lateral wall.
Table 3. Ventricular deformation.
THAL1 (9) THAL2 (14) C (12)
IVS SRpeak S -1.38±0.9 -1.39±0.6 -1.53±0.9
E 2.17±0.9
§ ﾰ∞ 2.54±1.0
ˈ 2.98±1.2
A 0.91±0.8
§ ﾰ∞ 1.41±1.0 1.26±1.0
IVS ʵ S 15.5±5.4
§ ﾰ 19.8±7.4
ˈ 24.6±9.2
LVW SRpeak S -1.66±1.0 -1.58±1.0 -1.34±0.6
E 2.05±1.4
ﾰ∞ 2.58±1.0 2.41±0.7
A 0.85±1.0
ﾰ∞ 0.71±0.7
ˈ 1.03±0.4
LVW ʵ S 18.1±10.7
ﾰ ∞20.0±9.0 23.4±9.7
THAL1 vs. THAL2: 
§p<0.05; 
§§p<0.01; 
§§§p<0.001; THAL1 vs. C: 
ﾰp<0.05; 
ﾰ ﾰp<0.01; 
ﾰﾰ ﾰ ﾰp<0.001; TAHL2 vs. C: 
ˈp<0.05; 
ˈˈp<0.01; 
ˈˈˈp<0.001.
IVS SRpeak: strain rate systolic (S), early (E) and late (A) diastolic peak at basal segments of interventricular septum; IVSε: strain systolic
(S) peak at basal segments of interventricular septum; LVW SRpeak: strain rate systolic (S), early (E) and late (A) diastolic peak at basal
segments of left ventricular lateral wall; LVWε: strain systolic (S) peak at basal segments of left ventricular lateral wall. Article
[Heart International 2009; 4:e3] [page 11]
the THAL1 subgroup, which showed a high-
er  estimated  left  ventricular  end-diastolic
pressure;
b)the coexistence of a lower rate of myocardial
atrial deformability (strain rate), essentially
in the THAL1 subgroup; 
c)the strict relationships between left atrium
systolic and diastolic strain rate parameters
and the estimated end-diastolic left ventric-
ular pressure. 
Relatively  recent  profound  changes  have
been  made  in  the  management  of  patients
with THAL. Regular red blood cell transfusions
eliminate  the  complications  of  anemia  and
compensatory bone marrow expansion, permit
childhood development, and extend survival.
18
In parallel, repeated transfusions determine a
"second disease" while treating the first,
19 the
inexorable accumulation of iron in different
tissues (also myocardium) that, with no treat-
ment, is deadly in the second decade of life.
Furthermore, the prognosis of THAL over the
last 20 years has improved side by side with
the development of iron-chelating therapy for
iron overload. Without any chelating therapy,
myocardial  disease  remains  the  life-limiting
complication of transfusional iron overload. As
highlighted  over  30  years  ago,  if  irregularly
transfused,  unchelated  children  frequently
develop left ventricular hypertrophy and con-
duction  disturbances  by  late  childhood,  and
ventricular arrhythmias and refractory conges-
tive failure by their mid-teens.
20
Comparison with previous studies
Within  the  heart,  even  small  amounts  of
unbound iron may generate harmful reactive
oxygen  metabolites  and  toxicity,  while  both
chronic  pulmonary  hypertension
21 and
myocarditis
22 may accelerate iron-induced car-
diac failure
23 in thalassemia. These observa-
tions  may  explain  the  unsettled  correlation
observed between the severity of myocardial
iron  deposition  and  that  of  cardiac  fibrosis.
Two trials, both covering over ten years, have
demonstrated  unequivocally  that  effective
long-term  use  of  deferoxamine  in  THAL  is
associated with long-term survival free of iron
overload complications.
24,25 Both studies identi-
fied the magnitude of body iron burden as the
principal  determinant  of  clinical  outcome.
Evidence  that  established  iron-induced  dys-
function of heart
26-28 and liver
29,30 might improve
during  intensive  deferoxamine  therapy  has
been  presented  in  several  reports.  Cardiac
biopsy or NMR remain the main procedures for
detecting  iron  deposits  in  heart.
Demonstrating hemosiderin in cardiac biopsy
material is used in the diagnosis of cardiac
iron overload; the hemosiderin deposition is
greatest  in  the  subepicardial  myocardium.
Myocardial fibrosis is, at most, mild. On the
other hand conventional echocardiogram may
show advanced iron-induced cardiac disease,
but it is not sufficiently sensitive for the early
detection  of  iron-induced  cardiac  dysfunc-
tion.
31,32 In  fact,  previous  echocardiographic
studies of patients with THAL and secondary
iron overload disclosed alterations of left ven-
tricular diastolic function, which precedes any
systolic dysfunction and increased myocardial
reflectivity. Our data can be added to previous
observations  confirming  what  is  already
shown in literature: with same age, hemoglo-
bin and ejection fraction, THAL patients pres-
ent an enlargement of left atrium and ventri-
cle, a faster peak of early diastolic flow and an
increase of the traditional parameters depend-
ing on preload.
33 The use of a highly sensitive
method such as CDMI, has enabled us to detect
very  early  and  subclinical  intra-myocardial
alterations both at ventricular and atrial level. 
With  PW-TDI,  we  found  lower  myocardial
velocities at mitral annulus level both in sys-
tole (global systolic longitudinal left ventricu-
lar  dysfunction)  and  in  diastole  (impaired
early  left  ventricular  diastolic  function).
Furthermore, an E/Em ratio>8, considered the
indicative cut-off of end-diastolic filling pres-
sure of the left ventricle,
15 was found in 65% of
thalassemic  patients.  These  data  were  con-
firmed  by  the  significantly  impaired  systolic
regional longitudinal function with CDMI both
at septum and at lateral wall level (significant-
ly lower strain both at septum and lateral wall).
It is relevant that these systolic alterations are
more significant in the THAL1 group. We could
hypothesize that such myocardial alterations
of both systolic and diastolic function could be
the expression of the early onset of an “iron
cardiomyopathy” and not only depend on vol-
ume  alterations,  as  previously  described  by
Chrysohoou.
34
It is interesting to analyze the data shown by
the two sub-groups of THAL patients: patients
presenting  supra-ventricular  arrhythmia
Figure  2.  Correlation  between
the  ratio  of  early  transmitral
flow  velocity/early  diastolic
velocity at mitral septal annulus
(E/Em, x axis) and the left ven-
tricular wall strain rate at peak
E (LVW SR-E, y axis) in all the
Thalassemic population. A sta-
tistically  significant  relation  is
observed.
Figure 3. Left panel: correlation between the ratio of early transmitral flow velocity/early
diastolic velocity at mitral septal annulus (E/Em, x axis) and the left atrial wall strain rate
at peak E (LAW SR-E, y axis) in all the Thalassemic population. Right panel: correlation
between the ratio of early transmitral flow velocity/early diastolic velocity at mitral later-
al annulus (E/Em, x axis) and the left atrial wall strain rate at peak S (LAW SR-S, y axis)
in all the Thalassemic population. A statistically significant relation is observed.
R 0.599
p<0.003
R 0.344
p<0.108
R 0.425
p<0.05
LAW SR-Epeak LAW SR-Speak
E/Em at septal mitral annulus
E/Em at septal mitral annulus E/Em at lateral mitral annulus
LVW SR-EpeakArticle
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(THAL1) showed a significant reduction of sys-
tolic and diastolic myocardial velocity at mitral
annulus level and an increased E/Em ratio and
were older than the thalassemic patients with-
out  arrhythmias  (THAL2).  These  findings
could give force to the hypothesis of a more
advanced  structural  cardiomyopathy  in  the
THAL1 subgroup. Moreover, the THAL1 group
showed a significant reduction of strain rate
value of the atrial wall in two of its components
(S and A). This reduction of the strain rate of
left  atrium  external  wall,  analyzed  following
Wang’s recent studies on patients with return
of the sinus rhythm after atrial fibrillation, rep-
resents a parameter able to identify those at
risk of relapsing arrhythmias.
35In fact our data,
focusing on the analysis of the deformation of
left atrium lateral wall, showed that patients
with lesser deformation speed are those who
were more frequently subject to supra-ventric-
ular  arrhythmias.  CDMI  derived  parameters,
such as E/Em and atrial strain and strain rate,
identified different behaviour between the two
groups  of  THAL  patients:  the  group  with
arrhythmias showed significantly lower values
of atrial strain and strain rate in relation to a
higher E/Em value. 
Conclusions
Color Doppler myocardial imaging, a rela-
tively novel echocardiographic technique, has
an incremental value in the follow-up analysis
of myocardial function in patients with THAL
who  underwent  iron-chelating  therapy.  With
this method it is possible to detect some subtle
atrial and ventricular myocardial alterations of
both systolic and diastolic function, not shown
by conventional echocardiography, which could
represent the onset of the development of an
“iron  cardiomyopathy”.  More  specifically  the
strain rate of the free wall of left atrium seems
to be related to the development of supra-ven-
tricular arrhythmias. The monitoring of these
parameters in the thalassemic population can
help identify those at risk of developing a car-
diomyopathy and/or supra-ventricular arrhyth-
mia and can promote earlier decision-making
on therapy and follow-up.
Study limitation
Our  study  has  two  limitations:  the  small
sample  size  and  demographic  differences
between  the  two  study  groups.  In  fact  the
patients in the THAL1 group were significantly
older than patients in the THAL2 group. Age
difference,  and  consequently  a  more  long-
standing disease and disease-related therapy
history, may account for the subtle differences
in myocardial structure and function observed
in the study. This, may suggest echo monitor-
ing and a more aggressive chelating therapy
(i.e. with new oral chelating therapy) in older
thalassemic patients.
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